iii jorn. nac. biosimilares - premios sefh biosim
Published 3 years ago • 76 plays • Length 22:24Download video MP4
Download video MP3
Similar videos
-
13:20
a phase 3 study of biosimilar bi 695501 versus adalimumab in patients with crohn’s disease - vjbm
-
0:51
skiepijimo (akiavimo) peilis due buoi 203c
-
6:57
maestro: phase iii study of evofosfamide (evo) in combination with gemcitabine...
-
2:44
fran lasowski, 3mt 2013
-
0:17
3a manual flow regulator asp00m
-
2:43
phase i dose escalation of imc-f106c - first prame × cd3 immtac bispecific protein in solid tumors
-
1:39
research that sheds light on the mechanism of action of pml in triple negative breast cancer
-
1:15
bio sb - 2021 new fgfr-3 antibody for ihc
-
0:43
are biosimilars safe?
-
2:31
einstein vision 3.0 fi
-
2:43
why do we need biosimilars?
-
2:12
midostaurin for newly diagnosed flt3 aml: radius-x efficacy and safety data
-
2:02
biologics and biosimilars
-
5:59
impassion130: atezolizumab and nab-paclitaxel in triple-negative breast cancer
-
1:46
pracinostat for aml update: follow-up analysis and phase iii trial
-
31:53
new technology of the quest mps3 system
-
1:34:59
iii jorn. nac. biosimilares - mesa 1 medicamentos biosimilares una herramienta para sostenibilidad
-
4:32
module 5: biosimilars—advances in research and development